Treatment comprising oral or gastric administration of edaravone

• 收藏
• 分享

专利权人:

Treeway TW001 B.V.

发明人:

Moolenaar, Sytske Hyke,Van Der Geest, Ronald

申请号：

AU2018209155

公开号：

AU2018209155A1

申请日:

2018.01.17

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The invention relates to a liquid pharmaceutical composition for use in medical treatment, said liquid pharmaceutical composition being a monophasic aqueous solution of non- complexed 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone) and comprising at least 7 wt.% water and 0.2-9mg/mL of edaravone, wherein the treatment comprises oral or gastric administration of 10-250 mL of the liquid pharmaceutical composition to provide 30-300mg edaravone.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/